CAZ Investments’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$34.9K	Sell	2,000 -500	-20%	-$8.73K	0.2%	20
2025 Q1	$31K	Hold	2,500	–	–	0.22%	21
2024 Q4	$26K	Hold	2,500	–	–	0.04%	29
2024 Q3	$36K	Sell	2,500 -7,500	-75%	-$108K	0.02%	27
2024 Q2	$85K	Buy	+10,000	New	+$85K	0.03%	22